3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Philadelphia Chromosome
1
Blast Crisis
1
Interventions
Imatinib Mesylate
12
nilotinib
3
bosutinib
3
peginterferon alfa-2a
2
asciminib
2
Dasatinib
2
Azacitidine
2
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide
2
venetoclax
1
thymoglobulin
1
flumatinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Rituximab
1
Mycophenolic Acid
1
Melphalan
1
Interferons
1
Dexamethasone
1
Clofarabine
1
Busulfan
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Antilymphocyte Serum
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Philadelphia Chromosome
×
Interferons
×
Myeloid
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled